Binding Site Information of Target
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T12837 | Target Info | |||
| Target Name | Histone-arginine methyltransferase CARM1 (CARM1) | ||||
| Synonyms | Protein arginine N-methyltransferase 4; PRMT4; Histonearginine methyltransferase CARM1; Coactivatorassociated arginine methyltransferase 1; Coactivator-associated arginine methyltransferase 1 | ||||
| Target Type | Literature-reported Target | ||||
| Gene Name | CARM1 | ||||
| Biochemical Class | Methyltransferase | ||||
| UniProt ID | |||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| Ligand Name: Tilarginine | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1, sinefungin, and methylated PABP1 peptide (R455) | PDB:5DX8 | ||||
| Method | X-ray diffraction | Resolution | 1.94 Å | Mutation | Yes | [1] |
| PDB Sequence |
RSVFSERTEE
143 SSAVQYFQFY153 GYLSQQQNMM163 QDYVRTGTYQ173 RAILQNHTDF183 KDKIVLDVGC 193 GSGILSFFAA203 QAGARKIYAV213 EASTMAQHAE223 VLVKSNNLTD233 RIVVIPGKVE 243 EVSLPEQVDI253 IISEPMGYML263 FNERMLESYL273 HAKKYLKPSG283 NMFPTIGDVH 293 LAPFTDEQLY303 MEQFTKANFW313 YQPSFHGVDL323 SALRGAAVDE333 YFRQPVVDTF 343 DIRILMAKSV353 KYTVNFLEAK363 EGDLHRIEIP373 FKFHMLHSGL383 VHGLAFWFDV 393 AFIGSIMTVW403 LSTAPTEPLT413 HWYQVRCLFQ423 SPLFAKAGDT433 LSGTCLLIAN 443 KRQSYDISIV453 AQVDQTGSKS463 SNLLDLKNPF473 FRYT
|
|||||
|
|
||||||
| Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
| Ligand Name: Sinefungin | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1, sinefungin, and PABP1 peptide (R455) | PDB:5DX1 | ||||
| Method | X-ray diffraction | Resolution | 1.93 Å | Mutation | Yes | [1] |
| PDB Sequence |
RSVFSERTEE
143 SSAVQYFQFY153 GYLSQQQNMM163 QDYVRTGTYQ173 RAILQNHTDF183 KDKIVLDVGC 193 GSGILSFFAA203 QAGARKIYAV213 EASTMAQHAE223 VLVKSNNLTD233 RIVVIPGKVE 243 EVSLPEQVDI253 IISEPMGYML263 FNERMLESYL273 HAKKYLKPSG283 NMFPTIGDVH 293 LAPFTDEQLY303 MEQFTKANFW313 YQPSFHGVDL323 SALRGAAVDE333 YFRQPVVDTF 343 DIRILMAKSV353 KYTVNFLEAK363 EGDLHRIEIP373 FKFHMLHSGL383 VHGLAFWFDV 393 AFIGSIMTVW403 LSTAPTEPLT413 HWYQVRCLFQ423 SPLFAKAGDT433 LSGTCLLIAN 443 KRQSYDISIV453 AQVDQTGSKS463 SNLLDLKNPF473 FRYT
|
|||||
|
|
PHE137
3.798
TYR149
3.498
PHE150
3.659
TYR153
3.451
GLN159
3.239
MET162
3.447
MET163
4.562
ARG168
2.636
ASP190
4.235
VAL191
4.547
GLY192
2.884
CYS193
3.398
GLY194
3.634
SER195
4.778
|
|||||
| Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
| Ligand Name: (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-azanylpropyl-[3-(pyridin-2-ylamino)propyl]amino]methyl]oxolane-3,4-diol | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 in complex with inhibitor AA175 | PDB:6S7A | ||||
| Method | X-ray diffraction | Resolution | 1.86 Å | Mutation | No | [2] |
| PDB Sequence |
SVFSERTEES
144 SAVQYFQFYG154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG 194 SGILSFFAAQ204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE 244 VSLPEQVDII254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL 294 APFTDEQLYM304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD 344 IRILMAKSVK354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA 394 FIGSIMTVWL404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK 444 RQSYDISIVA454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KY5 or .KY52 or .KY53 or :3KY5;style chemicals stick;color identity;select .A:137 or .A:149 or .A:150 or .A:153 or .A:159 or .A:162 or .A:163 or .A:168 or .A:169 or .A:172 or .A:191 or .A:192 or .A:193 or .A:194 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:218 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:258 or .A:259 or .A:266 or .A:268 or .A:271 or .A:415; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PHE137
3.828
TYR149
3.465
PHE150
3.548
TYR153
3.588
GLN159
3.324
MET162
3.635
MET163
3.662
ARG168
3.536
THR169
3.270
TYR172
4.523
VAL191
4.957
GLY192
3.262
CYS193
3.454
GLY194
3.703
ILE197
3.588
LEU198
3.793
|
|||||
| Ligand Name: (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(5-carbamimidamidopentyl)amino]-2-azanyl-butanoic acid | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 in complex with inhibitor WH5C | PDB:6S71 | ||||
| Method | X-ray diffraction | Resolution | 2.06 Å | Mutation | No | [2] |
| PDB Sequence |
SVFSERTEES
144 SAVQYFQFYG154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG 194 SGILSFFAAQ204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE 244 VSLPEQVDII254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL 294 APFTDEQLYM304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD 344 IRILMAKSVK354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA 394 FIGSIMTVWL404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK 444 RQSYDISIVA454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KYE or .KYE2 or .KYE3 or :3KYE;style chemicals stick;color identity;select .A:137 or .A:149 or .A:150 or .A:152 or .A:153 or .A:158 or .A:159 or .A:162 or .A:168 or .A:190 or .A:191 or .A:192 or .A:193 or .A:194 or .A:195 or .A:196 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:259 or .A:260 or .A:261 or .A:266 or .A:268 or .A:271 or .A:414 or .A:415; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PHE137
3.878
TYR149
3.412
PHE150
3.563
PHE152
4.631
TYR153
3.065
GLN158
4.677
GLN159
2.661
MET162
3.537
ARG168
3.316
ASP190
4.578
VAL191
4.863
GLY192
3.092
CYS193
3.395
GLY194
3.594
SER195
3.558
GLY196
4.636
ILE197
2.629
LEU198
3.416
|
|||||
| Ligand Name: (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-azanylpropyl-[3-(pyrimidin-2-ylamino)propyl]amino]methyl]oxolane-3,4-diol | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 in complex with inhibitor UM305 | PDB:6S74 | ||||
| Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [2] |
| PDB Sequence |
SVFSERTEES
144 SAVQYFQFYG154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG 194 SGILSFFAAQ204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE 244 VSLPEQVDII254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL 294 APFTDEQLYM304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD 344 IRILMAKSVK354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA 394 FIGSIMTVWL404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK 444 RQSYDISIVA454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KY8 or .KY82 or .KY83 or :3KY8;style chemicals stick;color identity;select .A:137 or .A:140 or .A:149 or .A:150 or .A:153 or .A:159 or .A:162 or .A:168 or .A:191 or .A:192 or .A:193 or .A:194 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:266 or .A:268 or .A:271 or .A:414 or .A:415; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PHE137
3.920
ARG140
4.945
TYR149
3.382
PHE150
3.473
TYR153
3.141
GLN159
3.214
MET162
3.661
ARG168
2.795
VAL191
4.774
GLY192
3.288
CYS193
3.370
GLY194
3.947
ILE197
4.341
LEU198
4.086
VAL213
4.134
GLU214
2.723
|
|||||
| Ligand Name: (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-(pyridin-2-ylamino)propyl]amino]-2-azanyl-butanoic acid | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 in complex with inhibitor AA183 | PDB:6S79 | ||||
| Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [2] |
| PDB Sequence |
SVFSERTEES
144 SAVQYFQFYG154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG 194 SGILSFFAAQ204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE 244 VSLPEQVDII254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL 294 APFTDEQLYM304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD 344 IRILMAKSVK354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA 394 FIGSIMTVWL404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK 444 RQSYDISIVA454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KXW or .KXW2 or .KXW3 or :3KXW;style chemicals stick;color identity;select .A:137 or .A:149 or .A:150 or .A:153 or .A:159 or .A:162 or .A:168 or .A:190 or .A:191 or .A:192 or .A:193 or .A:194 or .A:195 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:259 or .A:260 or .A:261 or .A:266 or .A:268 or .A:271 or .A:414 or .A:415; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PHE137
4.041
TYR149
3.350
PHE150
3.455
TYR153
3.566
GLN159
2.175
MET162
3.915
ARG168
3.074
ASP190
4.807
VAL191
4.870
GLY192
3.043
CYS193
3.439
GLY194
3.705
SER195
3.566
ILE197
3.186
LEU198
3.714
VAL213
4.037
|
|||||
| Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
| Ligand Name: 1-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]propyl]guanidine | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 in complex with inhibitor UM079 | PDB:6S7C | ||||
| Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | No | [2] |
| PDB Sequence |
SVFSERTEES
144 SAVQYFQFYG154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG 194 SGILSFFAAQ204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE 244 VSLPEQVDII254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL 294 APFTDEQLYM304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD 344 IRILMAKSVK354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA 394 FIGSIMTVWL404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK 444 RQSYDISIVA454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KY2 or .KY22 or .KY23 or :3KY2;style chemicals stick;color identity;select .A:137 or .A:140 or .A:149 or .A:150 or .A:153 or .A:158 or .A:159 or .A:162 or .A:168 or .A:190 or .A:191 or .A:192 or .A:193 or .A:194 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:259 or .A:260 or .A:261 or .A:266 or .A:268 or .A:271 or .A:414 or .A:415; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PHE137
3.866
ARG140
4.937
TYR149
3.327
PHE150
3.619
TYR153
3.380
GLN158
4.750
GLN159
3.844
MET162
3.531
ARG168
3.505
ASP190
4.915
VAL191
4.859
GLY192
2.976
CYS193
3.786
GLY194
3.834
ILE197
4.770
LEU198
3.801
VAL213
4.230
|
|||||
| Ligand Name: 1-[5-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]pentyl]guanidine | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 in complex with inhibitor UM251 | PDB:6S70 | ||||
| Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | No | [2] |
| PDB Sequence |
SVFSERTEES
144 SAVQYFQFYG154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG 194 SGILSFFAAQ204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE 244 VSLPEQVDII254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL 294 APFTDEQLYM304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD 344 IRILMAKSVK354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA 394 FIGSIMTVWL404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK 444 RQSYDISIVA454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KYB or .KYB2 or .KYB3 or :3KYB;style chemicals stick;color identity;select .A:137 or .A:149 or .A:150 or .A:153 or .A:158 or .A:159 or .A:162 or .A:168 or .A:191 or .A:192 or .A:193 or .A:194 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:266 or .A:268 or .A:271 or .A:414 or .A:415; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PHE137
3.920
TYR149
3.624
PHE150
3.523
TYR153
3.334
GLN158
4.637
GLN159
3.436
MET162
3.495
ARG168
3.609
VAL191
4.703
GLY192
3.095
CYS193
3.362
GLY194
3.714
ILE197
4.578
LEU198
3.825
VAL213
4.166
GLU214
2.628
|
|||||
| Ligand Name: 1-[4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azanylpropyl)amino]butyl]guanidine | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 in complex with inhibitor UM249 | PDB:6S7B | ||||
| Method | X-ray diffraction | Resolution | 2.66 Å | Mutation | No | [2] |
| PDB Sequence |
SVFSERTEES
144 SAVQYFQFYG154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG 194 SGILSFFAAQ204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE 244 VSLPEQVDII254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL 294 APFTDEQLYM304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD 344 IRILMAKSVK354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA 394 FIGSIMTVWL404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK 444 RQSYDISIVA454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .KYH or .KYH2 or .KYH3 or :3KYH;style chemicals stick;color identity;select .A:137 or .A:149 or .A:150 or .A:153 or .A:158 or .A:159 or .A:162 or .A:168 or .A:190 or .A:191 or .A:192 or .A:193 or .A:194 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:259 or .A:260 or .A:261 or .A:266 or .A:268 or .A:271 or .A:414 or .A:415; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PHE137
4.096
TYR149
3.610
PHE150
3.462
TYR153
3.321
GLN158
4.679
GLN159
3.554
MET162
3.533
ARG168
3.728
ASP190
4.980
VAL191
4.749
GLY192
3.213
CYS193
3.826
GLY194
3.871
ILE197
4.958
LEU198
4.205
VAL213
4.037
|
|||||
| Ligand Name: methyl 2-[2-[2-chloro-5-[(2R)-2-hydroxy-3-(methylamino)propoxy]phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-5-methylpyrimidin-4-yl]-2,7-diazaspiro[3.5]nonane-7-carboxylate | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 with EPZ022302 and SAH | PDB:6ARJ | ||||
| Method | X-ray diffraction | Resolution | 1.92 Å | Mutation | No | [3] |
| PDB Sequence |
RSVFSERTEE
143 SSAVQYFQFY153 GYLSQQQNMM163 QDYVRTGTYQ173 RAILQNHTDF183 KDKIVLDVGC 193 GSGILSFFAA203 QAGARKIYAV213 EASTMAQHAE223 VLVKSNNLTD233 RIVVIPGKVE 243 EVSLPEQVDI253 IISEPMGYML263 FNERMLESYL273 HAKKYLKPSG283 NMFPTIGDVH 293 LAPFTDEQLY303 MEQFTKANFW313 YQPSFHGVDL323 SALRGAAVDE333 YFRQPVVDTF 343 DIRILMAKSV353 KYTVNFLEAK363 EGDLHRIEIP373 FKFHMLHSGL383 VHGLAFWFDV 393 AFIGSIMTVW403 LSTAPTEPLT413 HWYQVRCLFQ423 SPLFAKAGDT433 LSGTCLLIAN 443 KRQSYDISIV453 AQVDQTGSKS463 SNLLDLKNPF473 FRYT
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .BW4 or .BW42 or .BW43 or :3BW4;style chemicals stick;color identity;select .A:149 or .A:152 or .A:153 or .A:162 or .A:168 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:265 or .A:266 or .A:268 or .A:340 or .A:414 or .A:415 or .A:470 or .A:472 or .A:474 or .A:476 or .A:477; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR149
3.819
PHE152
3.715
TYR153
3.302
MET162
3.183
ARG168
4.711
GLU257
2.633
PRO258
3.703
MET259
2.805
GLY260
4.250
TYR261
3.203
ASN265
3.331
|
|||||
| Ligand Name: (2R)-1-amino-3-{3-[4-(morpholin-4-yl)-1-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]phenoxy}propan-2-ol | Ligand Info | |||||
| Structure Description | Crystal structure of CARM1 with Compound 2 and SAH | PDB:6ARV | ||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [3] |
| PDB Sequence |
RSVFSERTEE
143 SSAVQYFQFY153 GYLSQQQNMM163 QDYVRTGTYQ173 RAILQNHTDF183 KDKIVLDVGC 193 GSGILSFFAA203 QAGARKIYAV213 EASTMAQHAE223 VLVKSNNLTD233 RIVVIPGKVE 243 EVSLPEQVDI253 IISEPMGYML263 FNERMLESYL273 HAKKYLKPSG283 NMFPTIGDVH 293 LAPFTDEQLY303 MEQFTKANFW313 YQPSFHGVDL323 SALRGAAVDE333 YFRQPVVDTF 343 DIRILMAKSV353 KYTVNFLEAK363 EGDLHRIEIP373 FKFHMLHSGL383 VHGLAFWFDV 393 AFIGSIMTVW403 LSTAPTEPLT413 HWYQVRCLFQ423 SPLFAKAGDT433 LSGTCLLIAN 443 KRQSYDISIV453 AQVDQTGSKS463 SNLLDLKNPF473 FRYT
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .BW7 or .BW72 or .BW73 or :3BW7;style chemicals stick;color identity;select .A:149 or .A:152 or .A:153 or .A:162 or .A:168 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:265 or .A:266 or .A:268 or .A:414 or .A:415 or .A:470 or .A:474 or .A:476 or .A:477; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: 2-{4-[3-Fluoro-2-(2-Methoxyphenyl)-1h-Indol-5-Yl] Piperidin-1-Yl}-N-Methylethanamine | Ligand Info | |||||
| Structure Description | CRYSTAL STRUCTURE OF COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) IN COMPLEX WITH SINEFUNGIN AND INDOLE INHIBITOR | PDB:2Y1W | ||||
| Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [4] |
| PDB Sequence |
SVFSERTEES
145 SAVQYFQFYG155 YLSQQQNMMQ165 DYVRTGTYQR175 AILQNHTDFK185 DKIVLDVGCG 195 SGILSFFAAQ205 AGARKIYAVE215 ASTMAQHAEV225 LVKSNNLTDR235 IVVIPGKVEE 245 VSLPEQVDII255 ISEPMGYMLF265 NERMLESYLH275 AKKYLKPSGN285 MFPTIGDVHL 295 APFTDEQLYM305 EQFTKANFWY315 QPSFHGVDLS325 ALRGAAVDEY335 FRQPVVDTFD 345 IRILMAKSVK355 YTVNFLEAKE365 GDLHRIEIPF375 KFHMLHSGLV385 HGLAFWFDVA 395 FIGSIMTVWL405 STAPTEPLTH415 WYQVRCLFQS425 PLFAKAGDTL435 SGTCLLIANK 445 RQSYDISIVA455 QVDQTGSKSS465 NLLDLKNPFF475 RYTG
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .849 or .8492 or .8493 or :3849;style chemicals stick;color identity;select .A:146 or .A:149 or .A:150 or .A:153 or .A:154 or .A:162 or .A:163 or .A:258 or .A:259 or .A:260 or .A:261 or .A:262 or .A:266 or .A:267 or .A:269 or .A:415 or .A:416 or .A:446 or .A:447 or .A:448 or .A:471; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
SER146
3.656
GLN149
3.396
TYR150
3.300
PHE153
3.347
TYR154
3.094
ASN162
4.475
MET163
3.805
GLU258
2.837
PRO259
3.416
MET260
3.000
GLY261
4.273
|
|||||
| Ligand Name: N-(3-{5-[5-(1H-Indol-4-YL)-1,3,4-oxadiazol-2-YL]-3-(trifluoromethyl)-1H-pyrazol-1-YL}benzyl)-L-alaninamide | Ligand Info | |||||
| Structure Description | CRYSTAL STRUCTURE OF COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) IN COMPLEX WITH SINEFUNGIN AND INDOLE INHIBITOR | PDB:2Y1X | ||||
| Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | No | [4] |
| PDB Sequence |
SVFSERTEES
145 SAVQYFQFYG155 YLSQQQNMMQ165 DYVRTGTYQR175 AILQNHTDFK185 DKIVLDVGCG 195 SGILSFFAAQ205 AGARKIYAVE215 ASTMAQHAEV225 LVKSNNLTDR235 IVVIPGKVEE 245 VSLPEQVDII255 ISEPMGYMLF265 NERMLESYLH275 AKKYLKPSGN285 MFPTIGDVHL 295 APFTDEQLYM305 EQFTKANFWY315 QPSFHGVDLS325 ALRGAAVDEY335 FRQPVVDTFD 345 IRILMAKSVK355 YTVNFLEAKE365 GDLHRIEIPF375 KFHMLHSGLV385 HGLAFWFDVA 395 FIGSIMTVWL405 STAPTEPLTH415 WYQVRCLFQS425 PLFAKAGDTL435 SGTCLLIANK 445 RQSYDISIVA455 QVDQTGSKSS465 NLLDLKNPFF475 RYT
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .845 or .8452 or .8453 or :3845;style chemicals stick;color identity;select .A:150 or .A:153 or .A:154 or .A:159 or .A:162 or .A:163 or .A:169 or .A:258 or .A:259 or .A:260 or .A:261 or .A:262 or .A:266 or .A:267 or .A:269 or .A:415 or .A:416 or .A:417 or .A:471 or .A:473 or .A:475 or .A:477; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR150
4.824
PHE153
3.660
TYR154
3.250
GLN159
3.133
ASN162
3.603
MET163
3.781
ARG169
4.966
GLU258
2.695
PRO259
3.727
MET260
2.909
GLY261
4.125
|
|||||
| Ligand Name: (2R,5S)-2-amino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-5-[(benzylamino)methyl]-N-[2-(4-methoxyphenyl)ethyl]hexanamide (non-preferred name) | Ligand Info | |||||
| Structure Description | Crystal structure of human CARM1 with (R)-SKI-72 | PDB:6DVR | ||||
| Method | X-ray diffraction | Resolution | 1.54 Å | Mutation | No | [5] |
| PDB Sequence |
QYFQFYGYLS
157 QQQNMMQDYV167 RTGTYQRAIL177 QNHTDFKDKI187 VLDVGCGSGI197 LSFFAAQAGA 207 RKIYAVEAST217 MAQHAEVLVK227 SNNLTDRIVV237 IPGKVEEVSL247 PEQVDIIISE 257 PMGYMLFNER267 MLESYLHAKK277 YLKPSGNMFP287 TIGDVHLAPF297 TDEQLYMEQF 307 TKANFWYQPS317 FHGVDLSALR327 GAAVDEYFRQ337 PVVDTFDIRI347 LMAKSVKYTV 357 NFLEAKEGDL367 HRIEIPFKFH377 MLHSGLVHGL387 AFWFDVAFIG397 SIMTVWLSTA 407 PTEPLTHWYQ417 VRCLFQSPLF427 AKAGDTLSGT437 CLLIANKRQS447 YDISIVAQVD 457 QTGSKSSNLL467 DLKNPFFRYT477 GTTPSPP
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .HDG or .HDG2 or .HDG3 or :3HDG;style chemicals stick;color identity;select .A:149 or .A:150 or .A:152 or .A:153 or .A:158 or .A:159 or .A:161 or .A:162 or .A:163 or .A:168 or .A:169 or .A:172 or .A:192 or .A:193 or .A:194 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:258 or .A:259 or .A:260 or .A:266 or .A:268 or .A:271 or .A:415; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR149
3.653
PHE150
3.374
PHE152
3.620
TYR153
3.082
GLN158
3.060
GLN159
3.138
ASN161
2.961
MET162
3.710
MET163
4.345
ARG168
2.531
THR169
3.608
TYR172
4.373
GLY192
3.336
CYS193
4.291
GLY194
3.831
ILE197
3.909
LEU198
3.568
|
|||||
| Ligand Name: 2,5,8,11,14,17-Hexaoxanonadecan-19-ol | Ligand Info | |||||
| Structure Description | Crystal structure of human CARM1 with (R)-SKI-72 | PDB:6DVR | ||||
| Method | X-ray diffraction | Resolution | 1.54 Å | Mutation | No | [5] |
| PDB Sequence |
QYFQFYGYLS
157 QQQNMMQDYV167 RTGTYQRAIL177 QNHTDFKDKI187 VLDVGCGSGI197 LSFFAAQAGA 207 RKIYAVEAST217 MAQHAEVLVK227 SNNLTDRIVV237 IPGKVEEVSL247 PEQVDIIISE 257 PMGYMLFNER267 MLESYLHAKK277 YLKPSGNMFP287 TIGDVHLAPF297 TDEQLYMEQF 307 TKANFWYQPS317 FHGVDLSALR327 GAAVDEYFRQ337 PVVDTFDIRI347 LMAKSVKYTV 357 NFLEAKEGDL367 HRIEIPFKFH377 MLHSGLVHGL387 AFWFDVAFIG397 SIMTVWLSTA 407 PTEPLTHWYQ417 VRCLFQSPLF427 AKAGDTLSGT437 CLLIANKRQS447 YDISIVAQVD 457 QTGSKSSNLL467 DLKNPFFRYT477 GTTPSPP
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .P15 or .P152 or .P153 or :3P15;style chemicals stick;color identity;select .A:149 or .A:152 or .A:153 or .A:161 or .A:162 or .A:165 or .A:168 or .A:259 or .A:260 or .A:261 or .A:265 or .A:266 or .A:414 or .A:415; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: (2S,5S)-2-amino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-5-[(benzylamino)methyl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide | Ligand Info | |||||
| Structure Description | Crystal structure of human CARM1 with (S)-SKI-72 | PDB:6D2L | ||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [6] |
| PDB Sequence |
QYFQFYGYLS
157 QQQNMMQDYV167 RTGTYQRAIL177 QNHTDFKDKI187 VLDVGCGSGI197 LSFFAAQAGA 207 RKIYAVEAST217 MAQHAEVLVK227 SNNLTDRIVV237 IPGKVEEVSL247 PEQVDIIISE 257 PMGYMLFNER267 MLESYLHAKK277 YLKPSGNMFP287 TIGDVHLAPF297 TDEQLYMEQF 307 TKANFWYQPS317 FHGVDLSALR327 GAAVDEYFRQ337 PVVDTFDIRI347 LMAKSVKYTV 357 NFLEAKEGDL367 HRIEIPFKFH377 MLHSGLVHGL387 AFWFDVAFIG397 SIMTVWLSTA 407 PTEPLTHWYQ417 VRCLFQSPLF427 AKAGDTLSGT437 CLLIANKRQS447 YDISIVAQVD 457 QTGSKSSNLL467 DLKNPFFRYT477
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FTG or .FTG2 or .FTG3 or :3FTG;style chemicals stick;color identity;select .A:149 or .A:150 or .A:152 or .A:153 or .A:159 or .A:162 or .A:163 or .A:168 or .A:169 or .A:191 or .A:192 or .A:193 or .A:194 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:218 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:265 or .A:266 or .A:268 or .A:271 or .A:414 or .A:415; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR149
4.021
PHE150
3.397
PHE152
3.913
TYR153
2.982
GLN159
3.449
MET162
4.323
MET163
3.907
ARG168
3.292
THR169
4.811
VAL191
4.825
GLY192
3.207
CYS193
4.012
GLY194
3.914
ILE197
3.455
LEU198
4.397
VAL213
4.011
GLU214
2.568
ALA215
3.126
|
|||||
| Ligand Name: N-Methyl-N-((2-(1-(2-(methylamino)ethyl)piperidin-4-yl)pyridin-4-yl)methyl)-3-phenoxybenzamide | Ligand Info | |||||
| Structure Description | Coactivator-associated arginine methyltransferase 1 with TP-064 | PDB:5U4X | ||||
| Method | X-ray diffraction | Resolution | 1.88 Å | Mutation | No | [7] |
| PDB Sequence |
SAVQYFQFYG
155 YLSQQQNMMQ165 DYVRTGTYQR175 AILQNHTDFK185 DKIVLDVGCG195 SGILSFFAAQ 205 AGARKIYAVE215 ASTMAQHAEV225 LVKSNNLTDR235 IVVIPGKVEE245 VSLPEQVDII 255 ISEPMGYMLF265 NERMLESYLH275 AKKYLKPSGN285 MFPTIGDVHL295 APFTDEQLYM 305 EQFTKANFWY315 QPSFHGVDLS325 ALRGAAVDEY335 FRQPVVDTFD345 IRILMAKSVK 355 YTVNFLEAKE365 GDLHRIEIPF375 KFHMLHSGLV385 HGLAFWFDVA395 FIGSIMTVWL 405 STAPTEPLTH415 WYQVRCLFQS425 PLFAKAGDTL435 SGTCLLIANK445 RQSYDISIVA 455 QVDQTGSKSS465 NLLDLKNPFF475 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .7VM or .7VM2 or .7VM3 or :37VM;style chemicals stick;color identity;select .A:146 or .A:149 or .A:150 or .A:153 or .A:154 or .A:162 or .A:163 or .A:258 or .A:259 or .A:260 or .A:261 or .A:262 or .A:266 or .A:267 or .A:269 or .A:415 or .A:416 or .A:446 or .A:447 or .A:448 or .A:470 or .A:471 or .A:472 or .A:473 or .A:475; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
SER146
4.654
GLN149
4.356
TYR150
3.669
PHE153
3.251
TYR154
3.349
ASN162
4.562
MET163
3.758
GLU258
2.566
PRO259
4.296
MET260
2.797
GLY261
4.761
TYR262
3.566
ASN266
2.827
|
|||||
| Ligand Name: (2s,5s)-2,6-Diamino-5-{[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydrofuran-2-Yl]methyl}hexanoic Acid | Ligand Info | |||||
| Structure Description | Crystal structure of coactivator-associated arginine methyltransferase 1 with methylenesinefungin | PDB:4IKP | ||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [8] |
| PDB Sequence |
ESSAVQYFQF
152 YGYLSQQQNM162 MQDYVRTGTY172 QRAILQNHTD182 FKDKIVLDVG192 CGSGILSFFA 202 AQAGARKIYA212 VEASTMAQHA222 EVLVKSNNLT232 DRIVVIPGKV242 EEVSLPEQVD 252 IIISEPMGYM262 LFNERMLESY272 LHAKKYLKPS282 GNMFPTIGDV292 HLAPFTDEQL 302 YMEQFTKANF312 WYQPSFHGVD322 LSALRGAAVD332 EYFRQPVVDT342 FDIRILMAKS 352 VKYTVNFLEA362 KEGDLHRIEI372 PFKFHMLHSG382 LVHGLAFWFD392 VAFIGSIMTV 402 WLSTAPTEPL412 THWYQVRCLF422 QSPLFAKAGD432 TLSGTCLLIA442 NKRQSYDISI 452 VAQVDQTGSK462 SSNLLDLKNP472 FFRY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .4IK or .4IK2 or .4IK3 or :34IK;style chemicals stick;color identity;select .A:149 or .A:150 or .A:153 or .A:159 or .A:162 or .A:168 or .A:190 or .A:191 or .A:192 or .A:193 or .A:194 or .A:195 or .A:196 or .A:197 or .A:198 or .A:213 or .A:214 or .A:215 or .A:216 or .A:240 or .A:241 or .A:242 or .A:243 or .A:257 or .A:259 or .A:266 or .A:268 or .A:271; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR149
3.394
PHE150
3.530
TYR153
2.915
GLN159
2.940
MET162
3.848
ARG168
2.841
ASP190
4.479
VAL191
4.640
GLY192
3.216
CYS193
3.287
GLY194
3.491
SER195
3.393
GLY196
4.600
ILE197
3.282
|
|||||
| Ligand Name: N'-[[3-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-5-methyl-6-(oxan-4-ylamino)pyrimidin-2-yl]phenyl]methyl]-N-methyl-ethane-1,2-diamine | Ligand Info | |||||
| Structure Description | CARM1 bound with compound 9 | PDB:7FAI | ||||
| Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [9] |
| PDB Sequence |
SAVQYFQFYG
154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG194 SGILSFFAAQ 204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE244 VSLPEQVDII 254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL294 APFTDEQLYM 304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD344 IRILMAKSVK 354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA394 FIGSIMTVWL 404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK444 RQSYDISIVA 454 QVDQTGSKSS464 NLLDLKNPFF474 RYT
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .XJ3 or .XJ32 or .XJ33 or :3XJ3;style chemicals stick;color identity;select .A:149 or .A:152 or .A:153 or .A:158 or .A:162 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:265 or .A:266 or .A:268 or .A:414 or .A:415 or .A:470 or .A:472 or .A:474 or .A:476 or .A:477; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR149
3.817
PHE152
3.726
TYR153
3.162
GLN158
4.750
MET162
3.599
GLU257
2.945
PRO258
3.926
MET259
3.209
GLY260
4.200
TYR261
3.279
|
|||||
| Ligand Name: N'-[[3-[4-(3,5-dimethyl-1,2-oxazol-4-yl)-5-methyl-6-phenylazanyl-pyrimidin-2-yl]phenyl]methyl]-N-methyl-ethane-1,2-diamine | Ligand Info | |||||
| Structure Description | CARM1 bound with compound 43 | PDB:7FAJ | ||||
| Method | X-ray diffraction | Resolution | 2.25 Å | Mutation | No | [9] |
| PDB Sequence |
SSAVQYFQFY
153 GYLSQQQNMM163 QDYVRTGTYQ173 RAILQNHTDF183 KDKIVLDVGC193 GSGILSFFAA 203 QAGARKIYAV213 EASTMAQHAE223 VLVKSNNLTD233 RIVVIPGKVE243 EVSLPEQVDI 253 IISEPMGYML263 FNERMLESYL273 HAKKYLKPSG283 NMFPTIGDVH293 LAPFTDEQLY 303 MEQFTKANFW313 YQPSFHGVDL323 SALRGAAVDE333 YFRQPVVDTF343 DIRILMAKSV 353 KYTVNFLEAK363 EGDLHRIEIP373 FKFHMLHSGL383 VHGLAFWFDV393 AFIGSIMTVW 403 LSTAPTEPLT413 HWYQVRCLFQ423 SPLFAKAGDT433 LSGTCLLIAN443 KRQSYDISIV 453 AQVDQTGSKS463 SNLLDLKNPF473 FRY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .XJ4 or .XJ42 or .XJ43 or :3XJ4;style chemicals stick;color identity;select .A:149 or .A:152 or .A:153 or .A:158 or .A:162 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:265 or .A:266 or .A:268 or .A:414 or .A:415 or .A:470 or .A:472 or .A:474 or .A:476; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| Ligand Name: (2R)-1-(methylamino)-3-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)propan-2-ol | Ligand Info | |||||
| Structure Description | PRMT4 bound with a bicyclic compound | PDB:6IZQ | ||||
| Method | X-ray diffraction | Resolution | 2.45 Å | Mutation | No | [10] |
| PDB Sequence |
SAVQYFQFYG
154 YLSQQQNMMQ164 DYVRTGTYQR174 AILQNHTDFK184 DKIVLDVGCG194 SGILSFFAAQ 204 AGARKIYAVE214 ASTMAQHAEV224 LVKSNNLTDR234 IVVIPGKVEE244 VSLPEQVDII 254 ISEPMGYMLF264 NERMLESYLH274 AKKYLKPSGN284 MFPTIGDVHL294 APFTDEQLYM 304 EQFTKANFWY314 QPSFHGVDLS324 ALRGAAVDEY334 FRQPVVDTFD344 IRILMAKSVK 354 YTVNFLEAKE364 GDLHRIEIPF374 KFHMLHSGLV384 HGLAFWFDVA394 FIGSIMTVWL 404 STAPTEPLTH414 WYQVRCLFQS424 PLFAKAGDTL434 SGTCLLIANK444 RQSYDISIVA 454 QVDQTGSKSS464 NLLDLKNPFF474 RY
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .XJ2 or .XJ22 or .XJ23 or :3XJ2;style chemicals stick;color identity;select .A:152 or .A:153 or .A:158 or .A:161 or .A:162 or .A:168 or .A:192 or .A:257 or .A:258 or .A:259 or .A:260 or .A:261 or .A:266 or .A:268 or .A:414 or .A:415; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Structural Insights into Ternary Complex Formation of Human CARM1 with Various Substrates. ACS Chem Biol. 2016 Mar 18;11(3):763-71. | ||||
| REF 2 | Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4). Biochem J. 2020 Feb 28;477(4):787-800. | ||||
| REF 3 | Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma. Sci Rep. 2017 Dec 21;7(1):17993. | ||||
| REF 4 | Structural basis for CARM1 inhibition by indole and pyrazole inhibitors. Biochem J. 2011 Jun 1;436(2):331-9. | ||||
| REF 5 | Crystal structure of human CARM1 with (R)-SKI-72 | ||||
| REF 6 | Crystal structure of human CARM1 with (S)-SKI-72 | ||||
| REF 7 | TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma. Oncotarget. 2018 Apr 6;9(26):18480-18493. | ||||
| REF 8 | Crystal structure of coactivator-associated arginine methyltransferase 1 with methylenesinefungin | ||||
| REF 9 | Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy. J Med Chem. 2021 Nov 25;64(22):16650-16674. | ||||
| REF 10 | Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia. J Med Chem. 2019 Jun 13;62(11):5414-5433. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.